Clinical Trial Update: Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating venetoclax in combination with decitabine for adult acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: The Second Affiliated Hospital of Kunming Medical University | Conditions: Acute Myeloid Leukemia, Adult | Phase 2, Phase 3 | Status: UNKNOWN